Market expectations of PetIQ's future revenue decline could be suppressing the P/S ratio. With a lower growth forecast than the industry, it's understandable that PetIQ's P/S is below most companies. A strong share price rise seems unlikely under these circumstances.
Jefferies' analysts have faith in both Chewy and PetIQ as they are shielded from increasing pet care costs due to their strategic positions and target customer demographics. Expectations are high for Chewy's expansion in pet health and elsewhere, while PetIQ stands to gain from a rising focus on preventative pet health.
Both PetIQ's accrual ratio and its unusual items suggest that its statutory earnings are possibly conservative. Its potential to increase profit if unusual items do not reoccur indicates a hopeful future outlook.
Gainers: •$Affirm Holdings(AFRM.US)$+36.4% (also announces multi-year extension of exclusive partnership with SHOP in the US) •$Robinhood(HOOD.US)$+22.9% (Emergent Fidelity discloses 7.6% stake; Sam Bankman-Fried CEO of crypto exchange FTX is majority holder in fund) •$奮進集團(EDR.US)$+20% (in reaction to earnings) •$Coinbase(COIN.US)$+13% (in sympathy with HOOD news) •$德納維製藥(DVAX.US)$+11.5% (to join ...
Gainers: •$Intercept Pharmaceuticals(ICPT.US)$+25.7% (to sell license to commercialize Ocaliva outside the US to Advanz Pharma for upfront payment of $405 mln) •$美國雅保(ALB.US)$+13.9% (earnings reports) •$Booking Holdings(BKNG.US)$+10% (Booking Holdings' Outlook for a 'Busy' summer season drives the stock sharply higher) •$AxoGen(AXGN.US)$+9% (reports top-line results from RECON study of Avance Nerge Graft) •$積雲媒體(CMLS.US)$+7.2% (an...
PetIQ股票討論區
專欄Today's pre-market stock movers: RBLX, TTD, VLD, WYNN and more
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US)$+17%,$Workiva(WK.US)$ +15.3%,$Arlo Technologies(ARLO.US)$ +12%,$Array Technologies(ARRY.US)$ +10.3%,$Everbridge(EVBG.US)$ +9.7%,$Catalyst Pharmaceuticals(CPRX.US)$ +9.4%,$奧洛茲美醫療(HALO.US)$ +8.7%,$Velo3D(VLD.US)$ +7.6%,$CyberArk(CYBR.US)$ + 6.2%,$美國血液技術(HAE.US)$ +5.8%,$Jackson Financial(JXN.US)$ +5.7% (also increases dividend),$Axon Enterprise(AXON.US)$ +4.8%,...
專欄Today's pre-market stock movers: TSLA, TWTR, AFRM, DWAC and more
• $Affirm Holdings(AFRM.US)$ +36.4% (also announces multi-year extension of exclusive partnership with SHOP in the US)
• $Robinhood(HOOD.US)$ +22.9% (Emergent Fidelity discloses 7.6% stake; Sam Bankman-Fried CEO of crypto exchange FTX is majority holder in fund)
• $奮進集團(EDR.US)$ +20% (in reaction to earnings)
• $Coinbase(COIN.US)$ +13% (in sympathy with HOOD news)
• $德納維製藥(DVAX.US)$ +11.5% (to join ...
專欄Top upgrades and downgrades on 5/13
• $BLACKSTONE SECD LENDING FD(BXSL.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $26
• $Constellation Energy(CEG.US)$ : Guggenheim Upgrades to Buy from Neutral - PT $70 (from $51)
• $科帕控股(CPA.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $96
• $Krispy Kreme(DNUT.US)$ : HSBC Upgrades to Buy from Hold - PT $17
• $多鄰國(DUOL.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $98
•$奮進集團(EDR.US)$ : Barclay...
專欄Today's pre-market stock movers: BKNG, TWTR, SHOP, EBAY and more
• $Intercept Pharmaceuticals(ICPT.US)$ +25.7% (to sell license to commercialize Ocaliva outside the US to Advanz Pharma for upfront payment of $405 mln)
• $美國雅保(ALB.US)$ +13.9% (earnings reports)
• $Booking Holdings(BKNG.US)$ +10% (Booking Holdings' Outlook for a 'Busy' summer season drives the stock sharply higher)
• $AxoGen(AXGN.US)$ +9% (reports top-line results from RECON study of Avance Nerge Graft)
• $積雲媒體(CMLS.US)$ +7.2% (an...
暫無評論